Liposomal paclitaxel and capecitabine
Phase 1Small molecule
Liposomal paclitaxel and capecitabine is one of 32 small molecule programs targeting Gastric Carcinoma. It is currently in Phase 1.
1
Indications
2
Total Trials
0
Active Trials
31
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
36 competitors in Gastric Carcinoma
#DrugCompanyPhaseTrials
1Lynparza
AstraZenecaApproved
Lenvima
EisaiApproved
Eloxatin
TevaPhase 3
Taxol
TevaPhase 3
Xeloda
EEngelhard Arzneimittel GmbH & Co.KG
Phase 3
Taxotere
AAvyxa
Phase 3
Camptosar
EEastern Cooperative Oncology Group
Phase 3
RAD001
NovartisPhase 3
Folinic Acid
RochePhase 3
Camptosar
PfizerPhase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details